Sentences with phrase «at financial risk at»

There is no reason to put yourself at financial risk at the whim of a cheater.

Not exact matches

«In the financial industry, there's been a lot of debate, post — financial crisis, around different approaches to risk and gender difference,» says Brenda Trenowden, global head of funds at ANZ Banking Group in London and a member of the steering committee of the 30 % Club, which works to get more women on corporate boards.

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

In the Minutes from the January FOMC meeting, the Federal Reserve addressed the financial situation, and noted that the increasing role of bond and loan mutual funds could pose a liquidity risk if everyone tries to get out of the market at the same time.

Such statements are based on management's current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as (but not limited to) changes in raw materials prices, currency fluctuations, the pace at which cost - reduction projects are implemented and changes in general economic and financial conditions.

Those federal rules, which double down on restrictions adopted in 2014 and stern warnings to lenders issued by OSFI earlier this summer, require banks to qualify borrowers at higher interest rates, impose additional limits on mortgages for buyers with small down payments, and compel financial institutions to share the risk by taking out insurance policies on low - ratio mortgages.

Anything lower risked screwing up financial markets, or so policy makers believed at the time.

However, looking at DHS data on the arrest rate of illegal entrants at the Mexican border, Federico S. Mandelman, a research economist and associate policy adviser at the Federal Reserve Bank of Atlanta, and Andrei Zlate, a senior financial economist in the Boston Fed's Risk and Policy Analysis Unit, found the numbers have been plummeting.

Eventually, this will constrict your company's financial flexibility and could put the entire enterprise at risk.

According to UBS, certain cities have seen prices rise at rates that are potentially not sustainable - and eight of these financial centers are at risk of having real estate bubbles that could eventually deflate.

«If the private plan fails and the government decided to refer to the clause in Bank Recovery Resolution Directive (a European regulation) that permits extraordinary financial support, government's popularity could be at risk of severe deterioration,» he added.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

More than anything, you must scrutinize the organization for professionalism and personal fit, especially before joining non-profits that have stretched resources, as your reputation or financial assets may be put at risk.

«The FSB's initial assessment is that crypto - assets do not pose risks to global financial stability at this time,» board Chairman Mark Carney said in a letter on March 18.

Bhanu Baweja, head of emerging market cross asset strategy at UBS, says the tax, combined with other regulations, could help reduce financial risks.

«At the same time, there are clear downside risks: political uncertainty, including in Europe; the sword of protectionism hanging over global trade; and tighter global financial conditions that could trigger disruptive capital outflows from emerging and developing economies,» the former French finance minister said.

If I plan to invest dollars, I have to make sure those dollars are available without putting other financial obligations at risk.

«Moreover, holding the federal funds rate at its current level for too long could also encourage excessive risk - taking and ultimately undermine financial stability.»

Goldman Sachs recently hosted a conference call with Steve Kotran, partner and head of the financial advisory practice at the law firm Sullivan & Cromwell, and discussed some of the emerging risks to the M&A business.

In addition to its hiring programs, Dave's Killer Bread provides financial help to area organizations that support ex-cons and other at - risk populations, including Lake Oswego - based Project Pooch, which teaches incarcerated kids to train shelter dogs for adoption, and SE Works, a Portland - based work - force - development program.

It's not clear who at Goldman Sachs had chief responsibility for originating and structuring the loan to Banco Espirito Santo, though such a commitment typically has to move through the firmwide capital committee, which includes senior executives like Chief Financial Officer Harvey Schwartz and Chief Risk Officer Craig Broderick.

«Our overall mood influences our willingness to take risks,» said Victor Ricciardi, finance professor at Goucher College and co-editor of the book «Investor Behavior: The Psychology of Financial Planning and Investing.»

Though it initially slowed our growth down, by having low debt we never put the company at financial risk and built a strong foundation we can now leverage.»

«For people who have the risk tolerance, investing that money rather than paying off the mortgage is fine, but think about what would happen if the investments don't pan out and you still have to pay your mortgage,» says Craig Brimhall, vice president of Wealth Strategies at Ameriprise Financial.

At the time, TD was among the Top 10 banks in the structured - products market, a business built on arcane financial instruments that shift risk between balance sheets and was ultimately a compounding factor of the financial crisis.

We are at risk of seeing an exodus of our financial institutions and our brightest financial talents.»

Now, with the relatively recent string of primary dealer failures (Countrywide, Bear Stearns, Lehman, Merrill, and now MF Global), a rational observer might think the NY Fed had moved to beef up surveillance activities designed to protect the financial system from excessive risk taking at primary dealers.

«When misconduct is common and accepted by financial services professionals, the integrity of our entire financial system is at risk.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

According to Matt Murawksi, a financial planner at Goodstein Wealth Management, following these key steps can protect any entrepreneur from any situation and allow them to grow and protect their personal finances while taking risks in a new business.

Recently, Thomas Oberlechner, a founding partner and chief science officer at AltX, gave the example of how human - computer collaboration can enable investment decisions that are more closely aligned with people's decision style, investment preference, risk tolerance, crisis vulnerability, financial values, etc..

At least four states have moved to imposed some form of departmental cybersecurity rules on businesses, led by New York, which now requires financial companies to certify that they've addressed, among other things, third - party risks.

Staley told CNBC that given the high level of debt across the world, in particular among emerging markets where dollar - denominated debt has grown dramatically, many economies could be at risk if there were sudden changes in financial conditions.

But as Steve Bowman, executive vice-president and chief credit and risk officer at GM Financial, noted back in 2006, «the downside is that they enticed one million people who had not intended to make a purchase into buying a vehicle.»

Perhaps it's not quite the Austerity Games yet, but we are already at the point when very few countries in which the leadership is accountable to its populace will take on the financial and political risk of staging the Olympics.

The UK's Financial Conduct Authority warned in November that cryptocurrency CFDs «are extremely high - risk, speculative products» that «place you at risk of suffering significant losses.»

Attempts to reduce information flow put us at risk of failing to foresee the next Enron or the next financial crisis.

The stricter residential mortgage lending regulations introduced by the Office of the Superintendent of Financial Institutions were aimed at reducing risk in the market amid high housing prices.

In 2007 and 2008, we could do the calculations of how much that had to be paid by whom, and we can see that that wasn't going to happen, and that we were going to have a financial bust... By and large, economically we are at the part of the cycle that is not too hot and not too cold, and assets have the right risk premiums, and so on.

The federal banking regulator, the Office of the Superintendent of Financial Institutions, also last summer said it was reviewing domestic retail sales practices at Canada's key banks, focusing on «risk culture» and «the governance of sales practices.»

In the event of a breach, it could help with any fines and pay for forensic investigators to look into what caused it, says Charles Bretz, director of payment risk at Financial Services Information Sharing and Analysis Center (FS - ISAC).

All - in, Morgan Stanley thinks $ 3 billion of the ~ $ 24 billion spent on financial information is at risk if new players — headlined by chat product Symphony — make major inroads into the market.

Despite the potential risks of «sleeping with the enemy,» it's easy to see the appeal of the Amazon deal for Sears: the partnership marks «the broadest distribution of Kenmore,» Sears said, and comes at a time of abysmal financial results for Sears.

Lauren Lyons Cole, a certified financial planner and senior editor at Business Insider, explains the risks of investing in cryptocurrency.

«The question from a financial stability point of view is whether or not those measures, to the extent they encourage more credit and more investment, may not buy some more growth today, but increase the risk of some disruption in growth further down the road,» Carolyn Wilkins, the Bank of Canada's senior deputy governor, said at least week's press conference.

The graph also notes that when investors are feeling euphoria, they are at their «point of maximum financial risks» while depression corresponds with the «point of maximum financial opportunity.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«Without these speedy and forceful actions... more major financial firms would have failed, and the entire global financial system would have been at serious risk,» he says.

At financial institutions, where the firms» finances are the flip side of the investments they make, CFOs are also taking on more of the risk management function as well.

Medium - term risks are still elevated as financial vulnerabilities, which have built up during the years of accommodative policies, could mean a bumpy road ahead and put growth at risk.